Status:
WITHDRAWN
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Familial Hypercholesterolemia
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
This study will evaluate the effect of APL180 on endothelial function measured by forearm venous occlusion plethysmography in patients with familial hypercholesterolemia.
Eligibility Criteria
Inclusion
- Confirmed presence of familial hypercholesterolemia
- Women must be sterilized or post-menopausal
Exclusion
- Smoking an average of greater than 10 cigarettes per day
- History of cardiac events
- Very low or high body weight
- Treatment with fibrates or niacin
- High blood triglyceride levels
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00751608
Start Date
September 1 2006
End Date
February 1 2009
Last Update
September 23 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.